Syndax Pharmaceuticals Inc (SNDX)
Official siteHEALTHCARE • BIOTECHNOLOGY • NASDAQ
Market Cap: $850.77M
Last updated: Nov 17, 2026 at 11:06 AM ET
Syndax Pharmaceuticals Inc (SNDX) Competitors
The companies most similar to Syndax Pharmaceuticals are Annexon (ANNX), Structure Therapeutics Inc. American Depositary Shares (GPCR) and Janux Therapeutics (JANX). By market cap, Syndax Pharmaceuticals ranks 6th of the 13 companies on this page; Nurix Therapeutics (NRIX) is the largest at $1.69B.
Peer Comparison
SNDX's ROIC of -65.0% is below the peer median of -58.7%, and its revenue growth of 81.6% is above the median of -3.5%. Like the median peer, it pays no dividend.
| Company | Market cap | P/E | P/S | Net margin | ROIC | Rev growth | Div yield |
|---|---|---|---|---|---|---|---|
| Syndax Pharmaceuticals (SNDX) | $850.77M | N/A | 2.8x | -72.3% | -65.0% | 81.6% | 0.00% |
| Annexon Inc (ANNX) | $747.79M | N/A | N/A | 0.0% | -84.6% | 0.0% | 0.00% |
| Structure Therapeutics Inc. American Depositary Shares (GPCR) | $1.43B | N/A | N/A | 0.0% | N/A | 0.0% | 0.00% |
| Janux Therapeutics Inc (JANX) | $695.65M | N/A | 29.6x | 0.0% | N/A | -7.1% | 0.00% |
| Solid Biosciences LLC (SLDB) | $763.42M | N/A | N/A | 0.0% | N/A | -100.0% | 0.00% |
| Theravance Biopharma Inc (TBPH) | $884.18M | 95.1x | 8.4x | 51.6% | N/A | -20.9% | 0.00% |
| Nurix Therapeutics Inc (NRIX) | $1.69B | 6.4x | 2.3x | 42.0% | N/A | 8426.0% | 0.00% |
| Shattuck Labs Inc (STTK) | $473.57M | N/A | N/A | 0.0% | N/A | -66.6% | 0.00% |
| Jade Biosciences, Inc. (JBIO) | $1.03B | N/A | N/A | 0.0% | N/A | 0.0% | 0.00% |
| CytomX Therapeutics Inc (CTMX) | $444.73M | N/A | 31.0x | 0.0% | -32.8% | -71.7% | 0.00% |
| Design Therapeutics Inc (DSGN) | $670.46M | N/A | N/A | 0.0% | N/A | 0.0% | 0.00% |
| Immix Biopharma Inc (IMMX) | $657.09M | N/A | N/A | 0.0% | -14.9% | 0.0% | 0.00% |
| Inventiva Sa (IVA) | $879.90M | N/A | 133.4x | 0.0% | -327.7% | -76.7% | 0.00% |
| Peer median | $755.61M | 50.8x | 29.6x | 0.0% | -58.7% | -3.5% | 0.00% |
Similar Companies
These are the 12 companies most similar to Syndax Pharmaceuticals, ranked by how closely their business, size, sector and industry match. All 12 are in one industry, Biotechnology.
| Company | About | Peers |
|---|---|---|
| Annexon Inc (ANNX) | Annexon, Inc., a clinical-stage biopharmaceutical company, discovers and develops therapies for autoimmune and neurodegenerative diseases. | ANNX competitors |
| Structure Therapeutics Inc. American Depositary Shares (GPCR) | Structure Therapeutics Inc., a clinical stage global biopharmaceutical company, develops and delivers novel oral therapeutics to treat a range of chronic... | GPCR competitors |
| Janux Therapeutics Inc (JANX) | Janux Therapeutics, Inc., a biopharmaceutical company, develops therapies based on the patented Tumor Activated T Cell Engager (TRACTr) platform technology... | JANX competitors |
| Solid Biosciences LLC (SLDB) | Solid Biosciences Inc., a life sciences company, is dedicated to developing therapies for Duchenne muscular dystrophy (DMD) in the United States. | SLDB competitors |
| Theravance Biopharma Inc (TBPH) | Theravance Biopharma, Inc., a diversified biopharmaceutical company, discovers, develops, and markets organ-selective drugs in the United States, Europe... | |
| Nurix Therapeutics Inc (NRIX) | Nurix Therapeutics, Inc., a biopharmaceutical company, focuses on the discovery, development... | NRIX competitors |
| Shattuck Labs Inc (STTK) | Shattuck Labs, Inc., a clinical-stage biotechnology company, develops therapies for the treatment of cancer and autoimmune diseases in the United States. | STTK competitors |
| Jade Biosciences, Inc. (JBIO) | Jade Biosciences, Inc. is a biotechnology company that develops therapies for inflammation and immunology indications in patients living with autoimmune... | JBIO competitors |
| CytomX Therapeutics Inc (CTMX) | CytomX Therapeutics, Inc. is an oncology-focused biopharmaceutical company in the United States. | CTMX competitors |
| Design Therapeutics Inc (DSGN) | Design Therapeutics, Inc. develops therapies for the treatment of degenerative disorders caused by nucleotide repeat expansions. | DSGN competitors |
| Immix Biopharma Inc (IMMX) | Immix Biopharma, Inc., a clinical-stage biopharmaceutical company, is dedicated to the development of various tissue-specific therapies in oncology... | IMMX competitors |
| Inventiva Sa (IVA) | Inventiva SA, a clinical-stage biopharmaceutical company, focuses on the development of oral small molecule therapies for the treatment of non-alcoholic... |
Frequently Asked Questions About SNDX
Who are Syndax Pharmaceuticals' main competitors?
The companies most similar to Syndax Pharmaceuticals include Annexon (ANNX), Structure Therapeutics Inc. American Depositary Shares (GPCR), Janux Therapeutics (JANX), Solid Biosciences LLC (SLDB) and Theravance Biopharma (TBPH), listed from the closest match.
Who is Syndax Pharmaceuticals' biggest competitor?
Nurix Therapeutics (NRIX) is the largest of the similar companies at $1.69B; Annexon (ANNX) is the closest match by business profile, size, sector and industry.
How does SNDX stock compare with its competitors?
SNDX's P/S is 2.8x against a peer median of 29.6x; its net margin is -72.3% against a peer median of 0.0%.
Which of Syndax Pharmaceuticals' competitors pays a higher dividend?
Syndax Pharmaceuticals pays no dividend. None of the similar companies with available yields has a higher forward dividend yield.
Is Syndax Pharmaceuticals bigger than its competitors?
No. Syndax Pharmaceuticals is 6th by market cap among the 13 companies on this page; the largest is Nurix Therapeutics (NRIX) at $1.69B.
SNDX pages: Overview, Earnings, Forecast, Financials, Competitors